Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 189 publications
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.
Journal: JAMA
Published: May 11, 2026
Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.
Journal: Progress in cardiovascular diseases
Published: March 25, 2026
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients.
Journal: The American journal of cardiology
Published: February 26, 2026
Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM.
Journal: European journal of heart failure
Published: February 18, 2026
Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of Cardiology.
Journal: European heart journal. Cardiovascular Imaging
Published: January 30, 2026
Long PR Interval Leads to Atrial Remodeling, Fibrosis and Inducible Atrial Fibrillation in a Swine Model.
Journal: JACC. Clinical electrophysiology
Published: December 05, 2025
Aortic Stenosis as a Mechanical Stressor and Tissue Energetics: Consistent Clue with Hypertensive Stress Septal Sign.
Journal: Journal of clinical medicine
Published: December 03, 2025
Effect of Aficamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy in SEQUOIA-HCM.
Journal: Circulation. Heart failure
Published: November 08, 2025
SPIROMICS HF: Rationale, Design, and Reproducibility of Measures.
Journal: Circulation. Heart failure
Published: November 05, 2025
Entropy in Hypertrophic Cardiomyopathy: A New Layer in Risk Stratification for Sudden Cardiac Death.
Entropy in Hypertrophic Cardiomyopathy: A New Layer in Risk Stratification for Sudden Cardiac Death.
Journal: Circulation. Cardiovascular imaging
Published: October 29, 2025
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Baseline Characteristics, Drug Exposure, and Outcomes in an Exploratory Analysis From ODYSSEY-HCM.
Journal: Journal of the American College of Cardiology
Published: October 18, 2025
Last Updated: 09/26/2026